Andrew Saxon, MD
Personal Statement
My area of expertise is addiction psychiatry.
Department Affiliations
Centers/Programs
Training Programs
Scholarly Expertise
Teaching Philosophy
My training philosophy involves serving as a role model for my trainees as well as generally apply a supportive, Socratic method.
- NIDA Clinical Trials Network: Pacific Northwest Node
- Improving the implementation of smartphone-based contingency management in medical settings for the treatment of methamphetamine use disorder: a qualitative analysis of patient and clinician experiences
- Improving opioid use disorder treatment using contingency management via mHealth
- Impact of medical and recreational marijuana laws on cannabis, opioids and psychiatric medications: national study of VA patients, 2000 – 2024
- Preventing addiction related suicide
- Evaluating the Stepped Care for Opioid Use Disorder Train-the-Trainer (SCOUTT) Program
- Collaborating to Heal Addiction and Mental Health in Primary Care (CHAMP)
Recent Publications
Cannabis Use and Cannabis Use Disorder Among U.S. Adults with Psychiatric Disorders: 2001-2002 and 2012-2013.
(2024 Nov 12)
Subst Use Misuse
Hasin DS, Mannes ZL, Livne O, Fink DS, Martins SS, Stohl M, Olfson M, Cerdá M, Keyes KM, Keyhani S, Wisell CG, Bujno JM, Saxon A
(2024 Nov 12)
Subst Use Misuse
Hasin DS, Mannes ZL, Livne O, Fink DS, Martins SS, Stohl M, Olfson M, Cerdá M, Keyes KM, Keyhani S, Wisell CG, Bujno JM, Saxon A
Navigating new norms: Addiction specialists' perspectives on opioid use disorder treatments and policy challenges in the fentanyl era.
(2024 Oct 4)
Am J Addict
Weleff J, Christian NJ, Wang JX, Singh M, De Aquino JP, Saxon AJ, Vassallo GG
(2024 Oct 4)
Am J Addict
Weleff J, Christian NJ, Wang JX, Singh M, De Aquino JP, Saxon AJ, Vassallo GG
Revisiting Preaddiction.
(2024 Sep-Oct 01)
J Addict Med 18(5): 486-487
Miller SC, Levy S, Saxon AJ, Tetrault JM, Rosenthal RN, Wakeman S, Vocci F
(2024 Sep-Oct 01)
J Addict Med 18(5): 486-487
Miller SC, Levy S, Saxon AJ, Tetrault JM, Rosenthal RN, Wakeman S, Vocci F
Collaborating to heal addiction and mental health in primary care (CHAMP): A protocol for a hybrid type 2a trial.
(2024 Nov)
Contemp Clin Trials 146(): 107700
Fortney JC, Ratzliff AD, Blanchard BE, Ferro L, Rouvere J, Chase E, Duncan MH, Merrill JO, Simpson T, Williams EC, Austin EJ, Curran GM, Schoenbaum M, Heagerty PJ, Saxon AJ
(2024 Nov)
Contemp Clin Trials 146(): 107700
Fortney JC, Ratzliff AD, Blanchard BE, Ferro L, Rouvere J, Chase E, Duncan MH, Merrill JO, Simpson T, Williams EC, Austin EJ, Curran GM, Schoenbaum M, Heagerty PJ, Saxon AJ
Naltrexone augmented with prazosin for alcohol use disorder: results from a randomized controlled proof-of-concept trial.
(2024 Jul 21)
Alcohol Alcohol 59(5):
Simpson TL, Achtmeyer C, Batten L, Reoux J, Shofer J, Peskind ER, Saxon AJ, Raskind MA
(2024 Jul 21)
Alcohol Alcohol 59(5):
Simpson TL, Achtmeyer C, Batten L, Reoux J, Shofer J, Peskind ER, Saxon AJ, Raskind MA
Show complete publication list »
